These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 19910836)

  • 1. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
    Fujita T; Nakagohri T; Gotohda N; Takahashi S; Konishi M; Kojima M; Kinoshita T
    Pancreas; 2010 Jan; 39(1):e48-54. PubMed ID: 19910836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of lymph node involvement and prognosis in pancreatic adenocarcinoma: direct lymph node invasion has similar survival to node-negative disease.
    Pai RK; Beck AH; Mitchem J; Linehan DC; Chang DT; Norton JA; Pai RK
    Am J Surg Pathol; 2011 Feb; 35(2):228-34. PubMed ID: 21263243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors after distal pancreatectomy with extended lymphadenectomy for invasive pancreatic adenocarcinoma of the body and tail.
    Shimada K; Sakamoto Y; Sano T; Kosuge T
    Surgery; 2006 Mar; 139(3):288-95. PubMed ID: 16546491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma.
    Kawai M; Tani M; Kobayashi Y; Tsuji T; Tabuse K; Horiuchi T; Oka M; Yamaguchi K; Sakata Y; Shimomura T; Yamaue H
    Am J Surg; 2010 Apr; 199(4):447-52. PubMed ID: 19596119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Yuasa Y; Kondo N; Ohge H; Sueda T
    J Am Coll Surg; 2010 Aug; 211(2):196-204. PubMed ID: 20670857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
    Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
    Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
    Sierzega M; Popiela T; Kulig J; Nowak K
    Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
    La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
    J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
    Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
    Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of para-aortic lymph node dissection in advanced gastric cancer.
    Kunisaki C; Shimada H; Yamaoka H; Wakasugi J; Takahashi M; Akiyama H; Nomura M; Moriwaki Y
    Hepatogastroenterology; 1999; 46(28):2635-42. PubMed ID: 10522056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
    Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
    Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
    Li XM; DI B; Shang YD; Li J; Cheng JM
    Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
    Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
    World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of lymph node metastases in the surgical management of pancreatic head carcinoma.
    Benassai G; Mastrorilli M; Mosella F; Mosella G
    J Exp Clin Cancer Res; 1999 Mar; 18(1):23-8. PubMed ID: 10374672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distal pancreatectomy--does it have a role for pancreatic body and tail cancer.
    Kayahara M; Nagakawa T; Ueno K; Ohta T; Kitagawa H; Arakawa H; Yagi H; Tajima H; Miwa K
    Hepatogastroenterology; 1998; 45(21):827-32. PubMed ID: 9684142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does the extent of lymph node dissection have an effect on morbidity and prognosis after resection of the head of the pancreas for ductal or periampullary pancreatic carcinoma?].
    Böttger T; Boddin J; Küchle R; Junginger T
    Langenbecks Arch Chir; 1997; 382(4):209-15. PubMed ID: 9445967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of factors influencing recurrence and metastasis following curative resection of pancreatic ductal adenocarcinoma].
    Xie YB; Zhao P; Wang CF; Shan Y; Zhao DB; Liu Q; Bai XF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):686-9. PubMed ID: 19173911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
    Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
    Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.